BASG and companies

News

News

Current issue of “RMS NEWS”

messages in brief | 31/03/2022
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

Current issue of “RMS NEWS”

messages in brief | 31/01/2022
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

Current issue of “RMS NEWS”

messages in brief | 30/09/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

Current issue of “RMS NEWS”

messages in brief | 30/06/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

Current issue of “RMS NEWS”

messages in brief | 30/04/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more

Information

Reporting to BASG

Reporting to BASG

The Federal Office relies on reports from consumers, health care professionals and companies for the continuous re-evaluation of the safety profile of medicinal products and medical devices.

Reporting to BASG read more
BREXIT

BREXIT

The transition period ended on 31.12.2020. Marketing authorisation holders are reminded to submit any outstanding amendments without delay.

BREXIT read more
Clinical Trials

Clinical Trials

The BASG authorises and monitors the conduct of clinical trials with medicinal products and medical devices.

Clinical Trials read more
Austrian Pharmacopoeia

Austrian Pharmacopoeia

The Austrian Pharmacopoeia (ÖAB) is a national addendum to the European Pharmacopoeia and is currently being revised by the ÖAB Commission.

Austrian Pharmacopoeia read more